Form 4: Zomedica Corp. Director Acquires Stock Appreciation Rights

Zomedica Corp. director Johnny D. Powers acquired 1,975,033 stock appreciation rights on November 11, 2024.

Summary

• On November 11, 2024, Johnny D. Powers, a director of Zomedica Corp., acquired 1,975,033 stock appreciation rights.
• These rights have an exercise price of $0.13.
• The stock appreciation rights are exercisable from November 10, 2025, and expire on November 10, 2034.
• The underlying security for these rights is 1,975,033 shares of Zomedica Corp. common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not contain any information that would indicate positive or negative sentiment. It is a neutral event.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock appreciation rights are a common form of equity compensation for directors and executives in publicly traded companies.
• The terms of these rights, such as the exercise price and vesting schedule, are typical for such instruments.
• The reporting of this transaction is in line with SEC regulations for insider trading.

Stakeholder Impact

• The acquisition of stock appreciation rights by a director may be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

stock appreciation rights, Zomedica Corp, director, insider trading, equity, compensation